Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? (Deficit) Equity

v3.23.1
Condensed Consolidated Statements of Stockholders’ (Deficit) Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   272,623,947      
Beginning balance at Dec. 31, 2021 $ 301,731 $ 27 $ 1,475,300 $ 7,538 $ (1,181,134)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income 7,748       7,748
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises (in shares)   843,591      
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises 169   169    
Issuance of Common Stock through settlement of restricted stock units (in shares)   1,817,226      
Issuance of Common Stock through settlement of restricted stock units 0        
Shares of Common Stock withheld related to net share settlement (shares)   607,936      
Shares of Common Stock withheld related to net share settlement (1,903)   (1,903)    
Stock-based compensation expense 48,704   48,704    
Foreign currency translation adjustment (4,473)     (4,473)  
Ending balance (in shares) at Mar. 31, 2022   274,676,828      
Ending balance at Mar. 31, 2022 351,976 $ 27 1,522,270 3,065 (1,173,386)
Beginning balance (in shares) at Dec. 31, 2022   297,230,671      
Beginning balance at Dec. 31, 2022 25,110 $ 30 1,572,576 (7,621) (1,539,875)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (44,318)       (44,318)
Issuance of Common Stock through Bird Canada Inc. acquisition transaction (in shares)   18,204,365      
Issuance of Common Stock through Bird Canada Inc. acquisition transaction 3,696 $ 2 3,694    
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises (in shares)   1,252,409      
Issuance of Common Stock through exercise of stock options and expiration of repurchase provision for early exercises 205   205    
Issuance of Common Stock through settlement of restricted stock units (in shares)   2,442,036      
Shares of Common Stock withheld related to net share settlement (shares)   (13,373)      
Shares of Common Stock withheld related to net share settlement (4)   (4)    
Stock-based compensation expense 7,280   7,280    
Foreign currency translation adjustment 461     461  
Ending balance (in shares) at Mar. 31, 2023   319,116,108      
Ending balance at Mar. 31, 2023 $ (7,570) $ 32 $ 1,583,751 $ (7,160) $ (1,584,193)